Perrigo (PRGO) Change in Intangibles (2015 - 2026)
Perrigo's (PRGO) quarterly Change in Intangibles came in at $1.4 million in Q1 2026, down 17.65% year-on-year from $1.7 million in Q1 2025, and down 41.67% on a QoQ basis from $2.4 million in Q4 2025.
Perrigo (PRGO) Change in Intangibles (2015 - 2026) Analysis & Trends
Perrigo (PRGO) has 12 years of Change in Intangibles data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Change in Intangibles fell 17.65% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $5.3 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $5.6 million, up 7.69% from the prior year.
- Change in Intangibles for Q1 2026 stood at $1.4 million, down from $2.4 million in the prior quarter.
- Over the last five years, Change in Intangibles for PRGO reached as high as $15.6 million in Q3 2023 and fell as low as $500000.0 in Q3 2025.
- Historically, Change in Intangibles has averaged $2.1 million across 5 years, with a median of $1.4 million in 2022.
- Across the five-year window, Change in Intangibles jumped 2500.0% in 2023 and slumped 94.23% in 2024, its largest moves.
- Year by year, Change in Intangibles stood at $600000.0 in 2022, then surged by 150.0% to $1.5 million in 2023, then advanced by 13.33% to $1.7 million in 2024, then surged by 41.18% to $2.4 million in 2025, then sank by 41.67% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Change in Intangibles figures were $1.4 million in Q1 2026, $2.4 million in Q4 2025, and $500000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -107.94 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | 1.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 1.40 Mn |
| Mar 28, 2026 | 1.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 27, 2025 | 500,000.00 |
| Sep 27, 2025 | 500,000.00 |
| Jun 28, 2025 | 1.00 Mn |
| Jun 28, 2025 | 1.00 Mn |
| Mar 29, 2025 | 1.70 Mn |
| Mar 29, 2025 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 28, 2024 | 1.00 Mn |
| Sep 28, 2024 | 1.00 Mn |
| Jun 29, 2024 | 900,000.00 |
| Jun 29, 2024 | 900,000.00 |
| Mar 30, 2024 | 1.60 Mn |
| Mar 30, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Dec 31, 2023 | 1.50 Mn |